Because of the crucial role of the CRTH2 in activation of allergic inflammation, CRTH2 agonists are widely recognised as a promising therapeutic target, especially in case of Th2 inflammation-driven asthma [87]. The gene discussed is PTGDR2; the disease is asthma.